Introduction
History
Clinical Manifestations and Classification
Viral Etiologies
Cytomegalovirus (CMV)
Herpes Simplex Virus (HSV)
Myxovirus Parotitis (Mumps) Virus
Other Viral Causes
Bacterial Etiologies
Drug-Induced
Procedural Causes
Corneal Cross-Linking (CCL)
Posterior Chamber Intraocular Lens Implantation
Allograft Rejection
Other Procedural Causes
Other Causes
Fungal Infection
Zoological Etiologies
Contact Lenses
Environmental
Exercise
Systemic Diseases
Retinoblastoma
Hypotony
Idiopathic
Diagnosis
Treatment
Causative agent | Presentation | Diagnostic test | Treatment |
---|---|---|---|
Viral | |||
CMV | Unilateral, linear or coin-shaped KP, anterior uveitis, stromal edema, iritis, elevated IOP, patient is immunocompetent | PCR analysis of viral genome in sample of aqueous humor via AC tap is the gold standard; serum IgG and IgM have also demonstrated effectiveness | Oral (900–1800 mg daily) valganciclovir or IV (5–10 mg/kg) ganciclovir, can add topical ganciclovir (0.15%) for greater efficacy Topical corticosteroids or topical NSAIDs per clinical judgment |
HSV | Unilateral, disciform KP, (can present with linear or diffuse KP), iritis, stromal edema, elevated IOP | PCR analysis of viral genome in sample of aqueous humor via AC tap is the gold standard; serum IgG and IgM have also demonstrated effectiveness | Oral acyclovir 400 mg 3–5 times daily and oral valaciclovir 500 mg 2 times daily Topical administration of acyclovir of is not indicated when confined to the endothelium Topical corticosteroids or topical NSAIDs per clinical judgment |
Mumps | Unilateral, central corneal edema sparing the epithelium, KP in the area of edema, elevated IOP, decreased visual acuity, ocular discomfort, recent mumps infection, absence of uveitis and iritis | PCR analysis of viral genome in sample of aqueous humor via AC tap is the gold standard; serum IgG and IgM have also demonstrated effectiveness | Topical corticosteroids only |
Bacterial | |||
Pseudomonas aeruginosa (most common) | Rapid onset pain, redness, photophobia, discharge, decreased visual acuity, commonly contact lens overuse | Corneal scrapings for smear and culture will reveal the causative agent | Consider 4th generation fluoroquinolone as first line of treatment with consideration of aminoglycosides for unresponsive cases |
Staphylococcus aureus | Rapid onset pain, redness, photophobia, discharge, decreased visual acuity, commonly contact lens overuse | Corneal scrapings for smear and culture will reveal the causative agent | Consider 4th generation fluoroquinolone as first line of treatment with consideration of vancomycin for unresponsive cases |
Other causes | |||
Giant cell arteritis | Bilateral or unilateral, corneal edema and decompensation, KP, elevated BP, retinopathy, initially low IOP | Magnetic resonance angiography revealing stasis of ophthalmic arteries, gold standard is temporal artery biopsy | High dose oral or IV corticosteroids |
Sarcoidosis | Granulomas in multiple ocular and systemic tissues. Other ocular findings are that of mutton-fat KP, uveitis, and macular edema | Tissue biopsy of lung | Topical corticosteroids, cycloplegics, regional corticosteroid injections, systemic corticosteroids, and systemic immunosuppressive agents |
Secondary to cannabinoid use | Corneal edema with endothelial dysfunction | Patient history of frequent cannabinoid use, decreased endothelial cell count in confocal microscopy | Topical corticosteroids |
Drug-induced (amantadine, mitomycin C, ethyl alcohol) | Bilateral corneal edema, with endothelial dysfunction | Patient history of an offending drug (comprehensive list of drugs causing endothelial toxicity found in Table 2) | Discontinuation of offending drug, begin topical corticosteroids |
Venom ophthalmia | Corneal edema, superficial keratitis, pain, photophobia, iritis, conjunctival injection, corneal opacity | Patient history of handling venomous animals: frogs and snakes | Wash eye with BSS, and palliative support with corticosteroids |
Tarantula keratopathy | Corneal edema, superficial keratitis, pain, photophobia, mutton-fat KP, conjunctival injection | Patient history of handling tarantula | Removal of barbs and treat with topical corticosteroids |
Allograft rejection, corneal cross-linking, retained lens fragments, and vitreous incarceration after cataract surgery | History of procedure | Corneal edema on slit lamp exam | Management based on the underlying etiology, topical or systemic corticosteroids per clinical judgment |
Drug | Common use |
---|---|
Amantadine | Neuropsychiatric and antiviral drug that is routinely used in patients with depression, influenza A, and Parkinson’s disease |
Methylphenidate | ADHD and narcolepsy |
Ropinirole | Parkinson’s disease and restless leg syndrome |
Resiniferatoxin | Analgesic |
Memantine | Alzheimer’s disease |
Dorzolamide | Glaucoma and elevated IOP treatment |
Amiodarone | Antiarrhythmic |
Ethyl alcohol | Recreation |
Intracameral lidocaine* | Intraoperative anesthetic |
Phenylephrine* | Mydriatic (adrenergic agonist) |
Benzalkonium chloride | Preservative in medicated eye drops |
Mitomycin C | Antineoplastic, used in numerous intraocular surgeries |
Menadione | Used as vitamin K supplement; not common in developed countries |
Phenothiazines | Antipsychotic |
Tetracaine*, proparacaine* | Topical anesthetic |